Il Dong Pharmaceutical Co Ltd (249420) — Working Capital to Net Assets Ratio
Il Dong Pharmaceutical Co Ltd (249420) has a Working Capital to Net Assets ratio of -9.3% as of September 2025. Working capital of ₩-21.04 Billion (current assets of ₩222.38 Billion minus current liabilities of ₩243.42 Billion) is measured against net assets of ₩226.84 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Il Dong Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Il Dong Pharmaceutical Co Ltd Working Capital to Net Assets (2016–2024)
This chart shows how Il Dong Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at -9.3%, reflecting working capital of ₩-21.04 Billion against net assets of ₩226.84 Billion KRW. For the complete balance sheet picture, see 249420 total assets.
Annual Working Capital to Net Assets for Il Dong Pharmaceutical Co Ltd (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Il Dong Pharmaceutical Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Il Dong Pharmaceutical Co Ltd (249420) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -18.2% | ₩-28.98 Billion | ₩159.06 Billion | ₩246.99 Billion | ₩275.97 Billion | ▲ +26.9 pp |
| 2023 | -45.1% | ₩-78.55 Billion | ₩174.27 Billion | ₩235.68 Billion | ₩314.23 Billion | ▼ -30.6 pp |
| 2022 | -14.4% | ₩-28.61 Billion | ₩198.22 Billion | ₩282.03 Billion | ₩310.64 Billion | ▲ +21.2 pp |
| 2021 | -35.7% | ₩-57.28 Billion | ₩160.58 Billion | ₩300.48 Billion | ₩357.76 Billion | ▼ -54.6 pp |
| 2020 | 18.9% | ₩48.23 Billion | ₩254.55 Billion | ₩233.24 Billion | ₩185.01 Billion | ▲ +10.4 pp |
| 2019 | 8.5% | ₩21.52 Billion | ₩252.89 Billion | ₩233.37 Billion | ₩211.84 Billion | ▼ -8.7 pp |
| 2018 | 17.2% | ₩47.56 Billion | ₩276.82 Billion | ₩210.46 Billion | ₩162.90 Billion | ▲ +0.5 pp |
| 2017 | 16.7% | ₩47.61 Billion | ₩285.07 Billion | ₩205.02 Billion | ₩157.41 Billion | ▼ -11.7 pp |
| 2016 | 28.4% | ₩76.17 Billion | ₩268.41 Billion | ₩218.70 Billion | ₩142.53 Billion | — |